How to Scale Up PrEP

Oral PrEP is gaining momentum worldwide. More and more countries are approving it for daily use — and global demand is growing!

Introducing PrEP is a complex process, and there's no single mold for an effective program. But this section of PrEPWatch is a great place to start. Here you will find three sections to help navigate PrEP introduction.

A Framework for Scaling up PrEP

This section outlines the steps involved for introducing oral PrEP and provides links to specific tools and resources for the following steps:

value chain graphic

Implementation Initiatives and Partners

On this page you will find information and resources about oral PrEP programs being implemented now and the organizations funding them. These resources comprise a storehouse of tools developed by existing PrEP programs made available here for the planning and implementation of future programs.

Lessons from the Field

As oral PrEP rolls out in Eastern and Southern Africa, implementers are facing and overcoming real world obstacles. Lessons from the Field brings you these stories. Come here to learn from others, sharpen insights and find useful resources. Together, we will make HIV prevention and the implementation of PrEP smart, efficient and effective.

Visit these pages regularly as we will be adding resources on an ongoing basis.

Last updated March 21, 2017.

News Spotlight

  • FDA Approves Truvada as PrEP for Adolescents at Risk for HIV

    May 15, 2018

    The US Food and Drug Administration has expanded the approval of Truvada as pre-exposure prophylaxis (PrEP) against HIV to include adolescents. Truvada was approved as an HIV prevention method in 2012 but only for individuals age 18 and older. The new approval expands this indication to include adults and adolescents at risk for HIV.

    Read more

  • Early PrEP Uptake in Africa Study Gives Support for Possibility of Wider Acceptance

    May 9, 2018

    New findings show that nearly a fifth of adults whose risk for HIV infection made them eligible for free PrEP started taking the drug within 30 days — according to a study examining the impacts of health interventions across communities in two East African countries. The study’s authors conclude that this provides further evidence that widespread roll out of PrEP to individuals at high risks for infection across resource-limited communities is feasible.

    Read more